Covid Vaccine Map and tracker worldwide
22
Vaccines testing safety and dosage
14
Vaccines in expanded safety trials
9
Vaccines in large-scale efficacy tests
3
Vaccines approved for early or limited use
0
Vaccines approved for early or limited use
Companies developing covid vaccines
Total Covid Cases Worldwide:
Covid vaccine projects by phases:
APPROVED
Coming Soon ...
LIMITED
Company | Country | Combined/Limited |
|---|---|---|
CanSino Biologics | China | Limited |
Gamaleya Research Institutes | Russia | Limited |
Sinovac Biotech | China | Limited |
PHASE 3
Company | Country | Combined/Limited |
|---|---|---|
CanSino Biologics | China | Limited |
Gamaleya Research Institutes | Russia | Limited |
BioNTech + Pfizer + Fosun Pharma | Germany + United States + China | With Phase 2 |
AstraZeneca + University of Oxford | United Kingdom + Sweden | With Phase 2 |
Moderna + National Institutes of Health | United States | - |
Sinopharm + Wuhan Institute of Biological Products | China | - |
Sinopharm + Beijing Institute of Biological Products | China | - |
Sinovac Biotech | China | - |
Murdoch Children’s Research Institute | Australia | - |
PHASE 2
Company | Country | Combined/Limited |
|---|---|---|
BioNTech + Pfizer + Fosun Pharma | Germany + United States + China | With Phase 3 |
AstraZeneca + University of Oxford | United Kingdom | With Phase 3 |
Imperial College London + Morningside Ventures | United Kingdom + China | With Phase 1 |
AnGes + Osaka University + Takara Bio | Japan | With Phase 1 |
Arcturus Therapeutics + Duke-NUS Medical School | United States + Singapore | With Phase 1 |
Johnson & Johnson + Beth Israel Deaconess Medical Center | United States | With Phase 1 |
Novavax | United States | With Phase 1 |
Finlay Vaccine Institute | Cuba | With Phase 1 |
Vector Institute | Russia | With Phase 1 |
Bharat Biotech + Indian Council of Medical Research + National Institute of Virology | India | With Phase 1 |
Zydus Cadila | India | - |
CureVac | Germany | - |
Anhui Zhifei Longcom + Chinese Academy of Medical Sciences | China | - |
Chinese Academy of Medical Sciences | China | - |
PHASE 1
Company | Country | Combined/Limited |
|---|---|---|
Imperial College London + Morningside Ventures | United Kingdom + China | With Phase 2 |
AnGes + Osaka University + Takara Bio | Japan | With Phase 2 |
Arcturus Therapeutics + Duke-NUS Medical School | United States + Singapore | With Phase 2 |
Johnson & Johnson + Beth Israel Deaconess Medical Center | United States | With Phase 2 |
Novavax | United States | With Phase 2 |
Finlay Vaccine Institute | Cuba | With Phase 2 |
Vector Institute | Russia | With Phase 2 |
Bharat Biotech + Indian Council of Medical Research + National Institute of Virology | India | With Phase 2 |
Inovio | United States | - |
Genexine | South Korea | - |
Academy of Military Medical Sciences + Suzhou Abogen Biosciences + Walvax Biotechnology | China | - |
ReiThera + Lazzaro Spallanzani National Institute for Infectious Diseases | Italy | - |
Clover Biopharmaceuticals + Dynavax | China + United States | - |
Vaxine | Australia | - |
Medicago + GSK + Dynavax | Canada + United States | - |
University of Queensland + CSL | Australia | - |
Kentucky BioProcessing | United States | - |
Medigen + Dynavax | United States | - |
Adimmune | China | - |
West China Hospital of Sichuan University | China | - |
Merck + Themis Bioscience + Institut Pasteur | United States + Austria + France | - |
Research Institute for Biological Safety Problems | Kazakhstan | - |